Hombourg, France

Fabienne Ricklin

USPTO Granted Patents = 29 

 

 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Hombourg, FR (2003 - 2017)
  • Basel, CH (2021)

Company Filing History:


Years Active: 2003-2021

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):

Title: Fabienne Ricklin: A Pioneer in Medicinal Chemistry

Introduction: Fabienne Ricklin is a prominent inventor based in Hombourg, France, recognized for her significant contributions to the field of medicinal chemistry. With an impressive portfolio of 29 patents, she has been at the forefront of innovation in developing compounds that can be utilized as medicaments.

Latest Patents: Among her latest patents are advancements in pyridine and pyrazol derivatives. Her invention related to pyridine derivatives involves compounds of formula (I), where the R groups are defined in the description and claims. These compounds can play a crucial role as therapeutic agents. Similarly, her work on pyrazol derivatives details a compound of formula (I), with specific definitions for A and R, also intended for use as a medicament.

Career Highlights: Fabienne Ricklin has achieved a remarkable career within Hoffmann-La Roche Inc., a company renowned for its commitment to pioneering healthcare solutions. Her dedication and innovative spirit have significantly contributed to the company's objectives in developing groundbreaking therapeutic compounds.

Collaborations: In her journey, Fabienne has collaborated with other notable researchers such as Hans Hilpert and Alfred Binggeli. These partnerships have enhanced her research capabilities, fostering a collaborative environment for the advancement of medicinal chemistry.

Conclusion: Fabienne Ricklin stands out as an influential figure in the realm of medicinal chemistry. With her 29 patents, she has made substantial strides in developing valuable compounds for medical applications. Her ongoing work continues to inspire upcoming inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…